Care designed around how you want to feel and perform
Your symptoms, health history, laboratory data and long-term goals shape the conversation from the beginning.
The short answer
What is Physician-Supervised Peptide Therapy?
A peptide is a short chain of amino acids. Some peptide medicines are FDA-approved for specific diseases; many products promoted online for anti-aging, healing, muscle gain or weight loss are investigational, unapproved or labeled “research use only.” Therapy should begin with diagnosis and product-specific evidence—not a peptide trend.
Concerns it may address
A health or wellness concern that deserves a medical evaluation
Questions about FDA-approved peptide medicines versus compounded or research products
Need for safe sourcing, pharmacy verification and monitoring
Review of online claims before purchasing or self-injecting
Candidacy
Who may—or may not—be a candidate
Who may be considered
Candidacy exists only when a licensed clinician identifies a legitimate clinical goal, an evidence-supported product or carefully justified compounded need, and a monitoring plan. The fact that a substance is a peptide does not make it safe or appropriate.
When treatment may not be appropriate
Do not use products sold without a valid prescription, labeled for research use only, shipped from unknown sources or promoted with guaranteed cures. Pregnancy, cancer risk, endocrine disease, medication interactions and organ dysfunction may change suitability depending on the specific drug.
At a glance
Treatment facts
These are practical planning ranges, not promises. Your consultation determines the exact plan.
Treatment time
Consultation usually 30–60 minutes
Comfort / anesthesia
No anesthesia for consultation; treatment route depends on the approved product
Typical downtime
None for consultation; adverse effects are product-specific
When changes may appear
No universal timeline—depends on diagnosis, evidence and medication
How long results may last
Only while benefit, safety and legal access justify treatment
Treatments commonly considered
Individualized follow-up and laboratory monitoring
Your visit
What happens during treatment
Evaluate
A physician reviews symptoms, diagnoses, medicines, goals and whether established treatments should come first.
Plan & treat
The exact molecule, FDA status, human evidence, risks, pharmacy and legal availability are reviewed. “Peptide” is never treated as one category of efficacy.
Review & follow up
If a legitimate therapy is appropriate, prescription, monitoring and stopping rules are documented. Patients are directed to the Peptide Education Center for deeper evidence.
Informed choice
Important risks, limitations and alternatives
Risks & limitations
Unknown-source products may be counterfeit, contaminated, incorrectly dosed, nonsterile or a different substance entirely. Potential harm includes infection, allergic reaction, endocrine disruption, blood-sugar changes, organ injury, tumor-related concerns and permanent harm. Compounded drugs are not FDA-approved and do not undergo premarket review for safety, effectiveness or quality.
Alternatives to discuss
An FDA-approved treatment with stronger evidence
Diagnosis-specific care through primary care or a specialist
Nutrition, sleep, rehabilitation or hormone evaluation when appropriate
No treatment when evidence is inadequate or sourcing cannot be verified
Clinical judgment
Why provider experience matters
A well-versed physician distinguishes an approved medication from a marketing label, verifies the pharmacy and prescription pathway, monitors measurable outcomes and refuses products whose evidence or source does not support safe care.
Identity Aesthetics approach
Diagnosis and anatomy before a product or device
Conservative planning with candid limitations
Licensed-provider supervision and complication readiness
In-office and telehealth boundaries stated clearly
Access & cost
In-office versus telehealth
Consultations and appropriate follow-up may be in-office or by telehealth for patients physically located in one of the 16 states we serve, subject to law and clinical eligibility. Labs or in-person examination may be required.
Pricing: Consultation required. Laboratory testing is included in the program. Cost depends on the evaluation, the legally available medication, pharmacy and follow-up. No specific peptide or prescription is guaranteed.
When a prescription or compounded preparation is clinically appropriate, the dispensing pharmacy, facility classification and current license status matter. Compounded medications are not FDA-approved drug products.
No. Approval applies to a specific product and indication. Many peptides promoted online are investigational or unapproved for human use.
Is a compounded peptide the same as an FDA-approved drug?
No. Compounded medicines are not FDA-approved and do not undergo FDA premarket review. They may be appropriate only in limited patient-specific circumstances under applicable law.
How do I verify a pharmacy?
Confirm state pharmacy licensure, the dispensing pharmacy name and address, the prescription label, prescriber relationship and whether the product came through a legitimate patient-specific prescription. Avoid sellers that hide the source or require no prescription.
Where can I read the detailed evidence?
Use Identity Aesthetics’ Peptide Education Center for FDA-status distinctions, research-only compounds, sourcing checks and individual evidence guides.
Medical-content evidence review: July 30, 2026. Content is written for patient education and structured from current primary regulatory, labeling and professional sources. It has not been individualized to your medical history. Product labeling and guidance can change; a licensed Identity Aesthetics provider confirms current suitability, informed consent and treatment details before care.
Your next step
Make an informed plan
Bring your goals, questions, medication list and prior treatment history. We will help you decide whether Physician-Supervised Peptide Therapy—or an alternative—makes sense.